Medicare News, In Brief
Executive Summary
Part D Discounts On Low-Volume Claims
You may also be interested in...
Medicare Drug Price Substitution For Part B Proposed Again By CMS
The proposal to reimburse less for drugs that exceed a price substitution threshold, first made last year but never finalized, is part of the Physician Fee Schedule proposed rule for 2012.
Industry Pressures CMS To Hold ASP Plus 6 Percent Rate For Hospital Outpatient Drugs
CMS' proposal to bring the reimbursement rate for Medicare Part B drugs administered in hospital outpatient departments back to average sales price plus 6% for the first time since 2007 has resulted in a fresh wave of pressure from industry groups to keep it at that level.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.